Specify a stock or a cryptocurrency in the search bar to get a summary
Schrodinger Inc
SDGRSchrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York. Address: 1540 Broadway, New York, NY, United States, 10036
Analytics
WallStreet Target Price
31.45 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures SDGR
Dividend Analytics SDGR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SDGR
Stock Valuation SDGR
Financials SDGR
Results | 2019 | Dynamics |